Results 161 to 170 of about 7,605 (170)

Cyclic aristeromycin diphosphate ribose: A potent and poorly hydrolysable Ca2+-mobilising mimic of cyclic adenosine diphosphate ribose

FEBS Letters, 1996
Antony Galione, B V Potter
exaly  

Studies on poly (adenosine diphosphate-ribose). X. Properties of a partially purified poly (adenosine diphosphate-ribose) polymerase.

Archives of biochemistry and biophysics, 1972
M, Yamada, M, Miwa, T, Sugimura
openaire   +1 more source

The Effect of Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors on Biochemical Changes in Testicular Ischemia-Reperfusion Injury

Journal of Urology, 2003
Erdem Akbay, Murat Bozlu, Selahittin Cayan   +2 more
exaly  

POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE INHIBITION PRESERVES ERECTILE FUNCTION IN RATS AFTER CAVERNOUS NERVE INJURY

Journal of Urology, 2005
Serap Gur, , Csaba SZABÓ
exaly  

Salvage chemotherapy and maintenance therapy with poly adenosine diphosphate-ribose polymerase inhibitors for bevacizumab-resistant relapse of epithelial ovarian cancer

European Journal of Gynaecological Oncology (discontinued), 2022
exaly  

Purification of Poly(Adenosine Diphosphate Ribose) Polymerase from Pig Thymus

Biochemical Society Transactions, 1976
C, Tsopanakis, E A, McLaren, S, Shall
openaire   +2 more sources

Is it poly(adenosine 5′-diphosphate-ribose) polymerase or hypothermia? *

Critical Care Medicine, 2002
openaire   +1 more source

Olaparib maintenance therapy in patients with platinum‐sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy

Cancer, 2016
Ronnie Shapira Frommer, Tamar Safra, Charlie Gourley   +2 more
exaly  

Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions

Clinical Cancer Drugs, 2018
exaly  

POLY(ADENOSINE DIPHOSPHATE RIBOSE)POLYMERASE IN BULL SPERMATOZOA.

1977
B. FARINA, FARAONE MENNELLA, MARIA ROSARIA   +1 more
openaire   +1 more source